💊 Drugs • 12,141 recalls
Teva Pharmaceuticals USA
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
SCA Pharmaceuticals
Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.
West-Ward Columbus
Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.
Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
cGMP deviations
Mylan Institutional
Presence of Particulate Matter
cGMP deviations
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Lupin Pharmaceuticals
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
SUN PHARMACEUTICAL INDUSTRIES
Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).
Lack of Processing Controls (lack of assurance of conformity to specifications).